awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36478979-2EDA941A-5C30-4382-AE91-CD6854A8D608
Q36478979-2EDA941A-5C30-4382-AE91-CD6854A8D608
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36478979-2EDA941A-5C30-4382-AE91-CD6854A8D608
G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm.
P2860
Q36478979-2EDA941A-5C30-4382-AE91-CD6854A8D608
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36478979-2EDA941A-5C30-4382-AE91-CD6854A8D608
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b5cb4a8c0edd41afb546828616ff2d1f28a26936
P2860
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia.